Category Archives: Stem Cell Research

Stem Cell Research- Inventing The Future By: Ximena Ls … Continue reading →

Stem Cell Advances in Heart Disease: Generating Muscle within an Existing Heart | Deepak Srivastava Long-term stem cell-based strategies for heart disease aim to rebuild parts of the heart. But investigators like Deepak Srivastava are also looking into more near term goals to regenerate heart muscle from within the existing heart through direct reprogramming. Dr. Srivastava spoke about his recent work in this area to the CIRM Governing Board during the public seminar "Spotlight on Stem Cell Advances in Pediatric Heart Disease". Dr. Srivastava, a CIRM grantee, is director of the Roddenberry Center for Stem Cell Biology and Medicine at The Gladstone Institutes and UCSF. For more information about CIRM-funded heart disease research, please visit our fact sheet: http://www.cirm.ca.gov By: CIRMTV … Continue reading →

Joshua's Heart Story: Pediatric Heart Disease and the Promise of Stem Cell Advances The day before 9/11, just four months pregnant, Mary Goulart and her husband got devastating news from ultrasound results: their baby had several heart defects including a missing left ventricle. After birth, baby Joshua endured three open-heart surgeries and a massive stroke. Through years of various therapies and true determination, Joshua now 11 is doing remarkably well. In this video, Joshua's mom recounts his story to the CIRM Governing Board during a public seminar, Spotlight on Stem Cell Advances in Pediatric Heart Disease. Ms. Goulart tells the board she's very aware of the gift of life her son was given by modern medicine and that her family holds out hope for new advances in regenerative medicine because eventually Joshua will need a heart transplant unless other solutions are discovered. By: CIRMTV … Continue reading →

Stem Cell Advances in Pediatric Heart Disease: A Change of Heart | Deepak Srivastava One percent of live births have heart defects, the leading noninfectious cause of death in the 1st year. Using embryonic stem cell technology, Dr. Deepak Srivastava's lab has made many insights into understand the genetic networks that control heart development as well the genetic mutations that are involved in heart defects. With these findings in hand, Srivastava's lab is in a position to perform stem cell-based drug screening as well as bioengineering to develop treatments for heart disease and heart failure. Dr. Srivastava spoke about his work to the CIRM Governing Board during the public seminar "Spotlight on Stem Cell Advances in Pediatric Heart Disease". Dr. Srivastava, a CIRM grantee, is director of the Roddenberry Center for Stem Cell Biology and Medicine at The Gladstone Institutes and UCSF. For more information about CIRM-funded heart disease research, please visit our fact sheet: http://www.cirm.ca.gov By: CIRMTV … Continue reading →

Time to Play: DeadLock in Minecraft part 3 episode 1 I do apologize for the space in between the uploading of these videos. It will start speeding up now that I have a few problems fixed, like my quality (mostly visual), and how editing works. The only time consuming part now is exporting and uploading. Let me know of you want longer videos and more frequently, I'll see what I can do. Oh yeah..PART 3: the story REALLY starts to get interesting now....Also a small side note: stupid things like "stem cell research.." when talking about plants is not us. That's just what we were given to read...I think the writer confused stems of plants with the stem of the brain. By: ZhivagoCinema … Continue reading →

NEWS RELEASE EMBARGOED FOR RELEASE Until 2 p.m. ET, Feb. 27, 2013 TWICE GIVEN, TWICE USED: INFUSION OF STEM CELLS AND SPECIALLY GENERATED T-CELLS FROM SAME DONOR IMPROVES LEUKEMIA SURVIVAL Newswise SEATTLE In a significant advance for harnessing the immune system to treat leukemias, researchers at Fred Hutchinson Cancer Research Center for the first time have successfully infused large numbers of donor T-cells specific for a key anti-leukemic antigen to prolong survival in high-risk and relapsed leukemia patients after stem cell transplantation. Both the stem cells for transplant and the T-cells came from the same matched donors. Reporting results of a pilot clinical trial in the Feb. 27 issue of the journal Science Translational Medicine, researchers describe the use of T-cells that were taken from a donor, programmed in the lab to recognize the Wilms Tumor Antigen 1 (WT1) and kill leukemia cells, grown in large numbers, and then infused into patients to promote anti-leukemic activity. The WT1 protein is overexpressed in leukemias and is in part responsible for why the cells have become leukemic. The best results were achieved when some of the patients received T-cell clones that were exposed to interleukin 21 (IL-21) during the programming and growth … Continue reading →

Ostheoarthritis Stem Cell Info: Biol 11AM TR An informational video about the use of stem cell research to cure ostheoarthritis. By: cheesehead535 … Continue reading →

Feb. 26, 2013 Scientists have used sugar-coated scaffolding to move a step closer to the routine use of stem cells in the clinic and unlock their huge potential to cure diseases from Alzheimer's to diabetes. Stem cells have the unique ability to turn into any type of human cell, opening up all sorts of therapeutic possibilities for some of the world's incurable diseases and conditions. The problem facing scientists is how to encourage stem cells to turn into the particular type of cell required to treat a specific disease. But researchers at the University of Manchester's School of Materials and Faculty of Life Sciences have developed a web-like scaffold, coated with long-sugar molecules, that enhances stem-cell cultures to do just this. The scaffold is formed by a process known as 'electrospinning', creating a mesh of fibres that mimic structures that occur naturally within the body. The team's results -- presented in the Journal of Biological Chemistry -- are particularly promising, as the sugar molecules are presented on the surface of the fibres, retaining structural patterns important in their function. The sugars are also 'read' by the stem cells grown on the surface, stimulating and enhancing the formation of neuronal cell … Continue reading →

Washington, February 27 (ANI): Scientists have developed sugar-coated scaffolding to improve stem cell technology to cure some of the world's incurable diseases and conditions. Stem cells have the unique ability to turn into any type of human cell, opening up all sorts of therapeutic possibilities for diseases from Alzheimer's to diabetes. But how to encourage stem cells to turn into the particular type of cell required to treat a specific disease is the problem that scientists are facing now. Now researchers at the University of Manchester's School of Materials and Faculty of Life Sciences have developed a web-like scaffold, coated with long-sugar molecules, that enhances stem-cell cultures to do just this. The scaffold is formed by a process known as 'electrospinning', creating a mesh of fibres that mimic structures that occur naturally within the body. The team's results are particularly promising, as the sugar molecules are presented on the surface of the fibres, retaining structural patterns important in their function. The sugars are also 'read' by the stem cells grown on the surface, stimulating and enhancing the formation of neuronal cell types. "These meshes have been modified with long, linear sugar molecules, which we have previously shown play a fundamental … Continue reading →

KS3:4 Science - Stem Cell Research- The Issue Crown Copyright. Provided by Arts College Limited. artsuk.org Further resources available on http Licensed to Arts College Limited. Licence information available at: artsuk.org Embryonic stem cells and the future of Parkinson's Disease. Stephen Cuff is only 39, but he suffers from Parkinson's Disease and it has turned his life upside down. He can no longer look after his two children and basic day-to-day activities like shaving, takes him a long time. Conventional drugs have not been successful for Stephen, leaving him no option but to undergo brain surgery. Stephen's operation is successful, but it doesn't cure him. One potential future cure is embryonic stem (ES) cell therapy. This is being pioneered by the likes of Professor Ian Wilmut, who became famous when he cloned Dolly the sheep. Professor Wilmut introduces us to the concept of stem cells and the science behind them, whilst presenting his opinion of the technology. Alison Davies, the chair of No Less Human, is a wheelchair user who would refuse ES cell therapy if it were available. She offers a different ethical perspective as to why the use of ES cells should not be … Continue reading →